326 related articles for article (PubMed ID: 20112254)
1. A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma.
Cabibbo G; Enea M; Attanasio M; Bruix J; Craxì A; Cammà C
Hepatology; 2010 Apr; 51(4):1274-83. PubMed ID: 20112254
[TBL] [Abstract][Full Text] [Related]
2. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.
Cammà C; Schepis F; Orlando A; Albanese M; Shahied L; Trevisani F; Andreone P; Craxì A; Cottone M
Radiology; 2002 Jul; 224(1):47-54. PubMed ID: 12091661
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies.
Marelli L; Stigliano R; Triantos C; Senzolo M; Cholongitas E; Davies N; Yu D; Meyer T; Patch DW; Burroughs AK
Cancer Treat Rev; 2006 Dec; 32(8):594-606. PubMed ID: 17045407
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials.
Lu Z; Wen F; Guo Q; Liang H; Mao X; Sun H
Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):187-94. PubMed ID: 23134976
[TBL] [Abstract][Full Text] [Related]
5. The impact of newer treatment modalities on survival in patients with hepatocellular carcinoma.
Taura N; Hamasaki K; Nakao K; Ichikawa T; Nishimura D; Goto T; Fukuta M; Kawashimo H; Fujimoto M; Kusumoto K; Motoyoshi Y; Shibata H; Eguchi K
Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1177-83. PubMed ID: 16901768
[TBL] [Abstract][Full Text] [Related]
6. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
Wang W; Shi J; Xie WF
Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507
[TBL] [Abstract][Full Text] [Related]
7. Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma.
Giannini EG; Bodini G; Corbo M; Savarino V; Risso D; Di Nolfo MA; Del Poggio P; Benvegnù L; Farinati F; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Aliment Pharmacol Ther; 2010 Feb; 31(4):493-501. PubMed ID: 19912152
[TBL] [Abstract][Full Text] [Related]
8. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529
[TBL] [Abstract][Full Text] [Related]
9. Predictors of long-term survival in hepatocellular carcinomas: A longitudinal follow-up of 108 patients with small tumors.
Chang HC; Lin YM; Yen AM; Chen SL; Wu WY; Chiu SY; Fann JC; Lin YS; Chen HH; Liao CS
Anticancer Res; 2013 Nov; 33(11):5171-8. PubMed ID: 24222166
[TBL] [Abstract][Full Text] [Related]
10. Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation.
Cabibbo G; Genco C; Di Marco V; Barbara M; Enea M; Parisi P; Brancatelli G; Romano P; Craxì A; Cammà C
Aliment Pharmacol Ther; 2011 Jul; 34(2):196-204. PubMed ID: 21564144
[TBL] [Abstract][Full Text] [Related]
11. Chemoembolization and bland embolization: a critical appraisal.
Befeler AS
Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274
[TBL] [Abstract][Full Text] [Related]
12. Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
Choi JY
Oncology; 2011; 81 Suppl 1():141-7. PubMed ID: 22212948
[TBL] [Abstract][Full Text] [Related]
13. Comparison of current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials.
Li X; Dong M; Lin Q; Chen ZH; Ma XK; Xing YF; Wan XB; Wen JY; Wei L; Chen J; Wu XY
Asia Pac J Clin Oncol; 2013 Mar; 9(1):86-92. PubMed ID: 23279888
[TBL] [Abstract][Full Text] [Related]
14. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.
Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK
J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438
[TBL] [Abstract][Full Text] [Related]
15. Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?
Lencioni R; Chen XP; Dagher L; Venook AP
Oncologist; 2010; 15 Suppl 4():42-52. PubMed ID: 21115580
[TBL] [Abstract][Full Text] [Related]
16. Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma.
Yu Y; Lang QB; Chen Z; Li B; Yu CQ; Zhu DZ; Huang XQ; Zhai XF; Ling CQ
Chin Med J (Engl); 2009 Sep; 122(17):1990-5. PubMed ID: 19781383
[TBL] [Abstract][Full Text] [Related]
17. Locoregional therapies for hepatocellular carcinoma: which patients are most likely to gain a survival advantage?
Mahady SE; Charlton B; Fitzgerald P; Koorey DJ; Perry JF; Waugh RC; McCaughan GW; Strasser SI
J Gastroenterol Hepatol; 2010 Jul; 25(7):1299-305. PubMed ID: 20594260
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival.
Stuart KE; Anand AJ; Jenkins RL
Cancer; 1996 Jun; 77(11):2217-22. PubMed ID: 8635087
[TBL] [Abstract][Full Text] [Related]
19. Nationwide study of 4741 patients with non-B non-C hepatocellular carcinoma with special reference to the therapeutic impact.
Utsunomiya T; Shimada M; Kudo M; Ichida T; Matsui O; Izumi N; Matsuyama Y; Sakamoto M; Nakashima O; Ku Y; Kokudo N; Makuuchi M;
Ann Surg; 2014 Feb; 259(2):336-45. PubMed ID: 23673768
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma.
Cabibbo G; Petta S; Barbàra M; Missale G; Virdone R; Caturelli E; Piscaglia F; Morisco F; Colecchia A; Farinati F; Giannini E; Trevisani F; Craxì A; Colombo M; Cammà C;
Liver Int; 2017 Aug; 37(8):1157-1166. PubMed ID: 28061016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
